Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2004-06-09
2008-03-04
Yu, Misook (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023400
Reexamination Certificate
active
07339042
ABSTRACT:
Disclosed are methods and compositions for gene therapy for tumors. Cytotoxic agents are selectively expressed in endothelial cells of tumor blood vessels, and delivered to tumor cells adjacent to the blood vessels, producing a bystander effect such that all the cells in contact with the transfected cells are killed or permanently growth arrested. In particular, cytotoxic gene products secreted from the transfected cell using a secretory signal sequence, include a membrane permeability domain at the N- or C-terminus that can shuttle the cytotoxic domain into non-transfected cells and back into transfected cells.
REFERENCES:
patent: 2003/0104622 (2003-06-01), Robbins et al.
Gura (Science, 1997, 278:1041-1042.).
Mai et al (Nov. 1, 2001, Cancer Research, 61:7709-7712).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12:320).
Mai et al., A Proapoptotic Peptide for the Treatment of Solid Tumors, Cancer Res., 61:7709-7712, Nov. 1, 2001.
Aeder Sean E
Akerman & Senterfitt
University of Florida Research Foundation Inc.
Yu Misook
LandOfFree
Gene delivery to tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene delivery to tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene delivery to tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3965542